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Manipulating the cytoplasmic folding environment by increasing the intracellular concentration of 
folding modulators, such as chaperone molecules, causes the convenient production of heterologous 
proteins. Wrong selection of chaperones will negatively affect the host cells physiology and the 
production of heterologous proteins. Due to this reason, type and combination of chaperone molecules 
are crucial to produce more soluble and active form of target protein. In the current study, the co-
overproduction of five different combinations of 6 chaperones, comprising "DnaK/DnaJ/GrpE/GroES/ 
GroEL", "GroES/GroEL", "DnaK/DnaJ/GrpE", "GroES/GroEL/TF" and "TF" along with recombinant 
human basic fibroblast growth factor (rhbFGF) were studied. As a result, we proved that none of these 
combinations was able to completely prevent the formation of inclusion bodies, but co-overexpression 
of the bacterial chaperone system TF along with rhbFGF could significantly enhance the yield of 
soluble protein. Recombinant soluble hbFGF that co-expressed with TF was then purified from the cells 
and was found to be identical to the active rhbFGF expressed alone with respect to size and spectral 
properties.  
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Over-expression of heterologous proteins in the cyto-
plasm of E. coli is often accompanied by their accumu- 
lation into insoluble aggregates. The aggregated proteins 
lose  their  correct  conformations  and  are  deposited  to 
inclusion bodies known to be in the inactive form of the 
protein (Baneyx and Mujacic, 2004).  
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protein purification, there is no guarantee that the in vitro 
refolding will produce large amounts of biologically active 
product. On the other hand, conditions for refolding the 
aggregated protein to its native form have to be 
standardized for each protein separately and this is often 
both time-consuming and expensive (Tsumoto et al., 
2003). Thus, while targeted inclusion body formation may 
be valuable, being able to produce over-expressed soluble 
proteins in vivo remains a critical concern. It is now clear 
that solubility is the best criterion of recombinant protein 
quality. Therefore, acquisition of solubility is the main 
goal in protein production processes. 
Under normal circumstances of in vivo folding, mole-
cular chaperones modify the kinetic partitioning between 





and Sambrook, 1992). During over-expression of proteins 
in Escherichia coli, the bacterial chaperones might get 
titrated out and thus fail to meet the demand of an 
overload of nascent polypeptides (Schweder et al., 2002). 
In this regard, increasing the chaperone supply seems a 
noticeable solution to the problems arising from formation 
of inclusion bodies during over-production of recombinant 
proteins (Schlieker et al., 2002). 
Goloubinoff et al. (1989) first demonstrated that chape-
rone co-overexpression is a powerful tool to improving 
the folding of heterologous proteins by showing that the 
yield of active Aspergillus nidulanse RUBISCO was 
increased 10-folds in the cells harboring groELS operon. 
Subsequently, lots of attempts were made to increase the 
yields of correctly folded and soluble recombinant proteins 
by the co-overproduction of chaperones combination in 
producing cells.  
It is still a trial and error process to find a compatible 
chaperone system to increase the solubility of the target 
protein. For instance, GroELS or DnaKJ were effective 
for some proteins such as RUBISCO, human procolla-
genase, E. coli glutamate racemase but along with chlo-
ramphenicol acetyltransferase, yeast N-myristoyl trans-
ferase and β-galactosidase-bovine somatotropin fusion 
protein both chaperone systems demonstrate the lack of 
effect (Goloubinoff et al., 1989; Lee and Olins, 1992; 
Ferreyra et al., 1993). Nishahara et al. (2000) reported 
the effect of chaperone combinations on the three 
different aggregation prone proteins. They revealed that 
while over-production of DnaKJ plus GrpE or trigger 
factor alone was sufficient to improve the solubility of 
mouse endostatin, DnaKJ plus GrpE or trigger factor plus 
GroELS were effective for human oxygen-regulated 
protein ORP150 and only trigger factor plus GroELS were 
capable of improving solubility ratio of human lysozyme. 
All these studies show that while this approach has been 
very successful for a large number of unrelated sub-
strates, there is no guarantee that chaperones co-
overproduction will improve the folding of a recombinant 
protein.  
For the first time in this study, the capability of the 
molecular chaperone combinations inside the cell for the 
production of soluble well qualified recombinant human 
basic fibroblast growth factor (rhbFGF) was examined. 
For that reason, we used 5 different combinations of 6 
chaperone molecules. At the end, we report the confor-
mational quality of soluble rhbFGF produced by the best 
co-transformants using spectroscopic studies. 
 
 
MATERIALS AND METHODS 
 
Strain and plasmids 
 
E. coli OrigamiB (DE3) (Invitrogen, USA) was used  as  host. In  
ourprevious work, an expression vector for human basic fibroblast 
growth factor, pET-1008, was constructed as follows: A 450 bp 
DNA fragment containing the coding region for the mature cyto-
plasmic  isoform  of  hbFGF   was   inserted   into   pET-22b   vector  




(Novagen, UK) just downstream of its ATG initiation codon. 
Expression of the hbfgf gene was under the control of the T7 
promoter, induced by isopropyl-β-D-thio-galactoside (IPTG) 
(Alibolandi et al., 2010). 
The plasmids containing the chaperone gene(s) were purchased 
from Takara Company (Japan). All the chaperone plasmids were 
derivatives of pAR3 with a chloramphenicol-resistant marker.  
Plasmid pG-KJE8 contains the dnaK-dnaJ-grpE and groES-
groEL operons, respectively, fused with araB and Pzt-l promoters, 
while pG-Tf2 plasmid consists of trigger factor gene and groES-
groEL operon under control of tetracycline inducible promoter (Pzt-
1). pTF16 and pKJE7 plasmids, with the L-arabinose inducible 




Media and cultivation condition 
 
Co-transformed bacteria with pET-1008 and chaperone plasmids 
were grown in Lauria Bertani (LB) agar (Merck, USA) plate con-
taining ampicillin (50 µg/ml) and chloramphenicol (20 µg/ml). The 
plates were incubated at 37°C for approximately 15 h. For 
preparing the seed cultures, an isolated single colony of each co-
trasformant bacteria was picked to be inoculated into 5 ml of LB 
medium (Merck, USA). The medium was supplemented with 
ampicillin (50 µg/ml) and chloramphenicol (20 µg/ml) which was 
then incubated at 37°C overnight. 
 
 
Expression and analytical methods  
 
In order to achieve high yields of soluble rhbFGF, different incuba-
tion time, temperatures and concentration of inducers were tested 
in the expression procedure. To perform co-expression of rhbFGF 
along with each combination of chaperone, 2 ml of prepared seed 
cultures were inoculated into 100 ml of LB medium in the presence 
of related antibiotics for plasmid selection and 0.5 to 4 mg/ml L-
arabinose and/or 2 to 5 ng/ml tetracycline for the induction of 
chaperone expression, then were shaken in a rotatory shaker at 
37°C and 200 rpm. When the A600nm reached 0.5, the cultures were 
supplemented with 1 mM IPTG to induce the expression of the 
rhbfgf gene regulated by the T 7 promoters. After induction, the 
cultures were further shaken at 25, 30, 37°C and 200 rpm. Batch 
samples were taken every hour until OD600 reached 0.2.  
2.5 ml of culture samples were centrifuged at 6000 rpm for 10 
min.  The cell pellets were re-suspended in 100 µl of 50 mM 
phosphate buffer (pH 7.2) containing 0.1 mM phenylmethylsulfonyl 
fluoride (PMSF), 0.5 mM MgCl2, 1 mM EDTA and 250 µg/ml 
lysozyme. The suspension was kept on ice for 30 min and cells 
were then sonicated (3 times, 30 seconds each time) using an ultra-
sonic processor (Misonix, NY). The cell extracts were centrifuged at 
4°C and 10000 rpm for 15 min.  
For precise measurement of soluble hbFGF, the supernatants 
containing soluble proteins were assayed by the enzyme-linked 
immunosorbent assay (ELISA) kit (R&D, USA). The pellets 
containing insoluble proteins were re-suspended in 100 µl of 50 mM 
phosphate buffer (pH 7.2). For measurement of insoluble hbFGF, 
the same ELISA kit was employed. All ELISA tests were done in 
triplicate.  Soluble and insoluble fractions were normalized with res-
pect to cell density and loaded on 15% sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) under reducing 
conditions (Laemmli, 1970) and stained with coomassie brilliant 
blue R250 (Sigma, USA).  
The protein concentrations in the samples were determined  with 
Bradford method (Bradford, 1976) using bovine serum albumin as 
the concentration standard. For Western blotting assay, soluble and 
insoluble fractions of 6 expression systems lysate in the gel were 
transferred   to   a   0.2 µm   pore   size    nitrocellulose   membrane 






Figure 1. SDS-PAGE analysis. The soluble (S) and insoluble 





(schlecher and Schuell, USA) using a semi-dry electroblotting 
apparatus (Bio-Rad, USA) at 12 V for 45 min. Rabbit anti-hbFGF 
anti serum (Sigma, USA) served as primary antibody and the 
secondary antibody, horse radish peroxidase conjugated goat-anti-
rabbit antibody (Sigma, USA) was added followed by incubation at 
room temperature for 2 h. The immunoreactions were visualized 
using 0.5 mg/ml diaminobenzidine HCl and 0.01% H2O2.  
 
 
Purification of recombinant hbFGF 
 
The lysates obtained from 1 liter of induced cell cultures for best 
transformant and co-transformant, were centrifuged at 4°C and 
10000 rpm for 15 min.  Supernatants containing the soluble fraction 
were ultrafiltrated using centricon plus-70 (ultracell cut off 30000 
Da, Millipore, USA), at 3000 g for 15 min. The proteins that passed 
through the ultrafilter were run on a 25 ml CM sepharose column 





protocol of Alibolandi et al. (2010). 
The purity of the recombinant protein and yields of purified 
protein were quantified by densitometry scan of 1-D gels using 
Quantity-One 1D-gel analysis software (Bio-Rad, USA). Thermal 
denaturation was used in order to prepare denatured protein for 
spectroscopic studies. For preparation of 0.5 mg denatured hbFGF, 
0.8 mg purified hbFGF in phosphate buffer pH = 7 was incubated at 
65°C for about 15 min. 
 
 
Circular dichroism (CD) 
 
CD spectroscopy was used to determine the recombinant hbFGF 
secondary and tertiary structures using JASCO J-810 spectro-
polarimeter. All spectra were recorded using 1mm pathlength 
cuvette, scanning rate of 200 nm/min and 1 nm bandwidth. The 
protein concentration of about 0.5 mg/ml was used for each CD 






Determination of protein fluorescence spectrum was performed with 
a Hitachi F-4010 fluorescence spectrophotometer using a quartz 
cuvette with 1 cm light path-length. Excitation and emission slits 
were set as 10 nm. Fluorescence spectra were then recorded with 
an excitation of 295 nm and recording the emission spectra from 





Expression of recombinant human basic fibroblast 
growth factor 
 
Figure 1 shows the soluble/insoluble fractions of pET-
1008 (rhbfgf-cDNA inserted into pET-22b) expression 
under the regulation of the T 7 promoter in the OrigamiB 
(DE3) strain. The result implies that rhbFGF can be 
properly expressed but process to form native form of the 
protein is deficient. Under optimal conditions for produc-
tion of soluble hbFGF (Table 1), more than 80% of 
produced rhbFGF were deposited to insoluble fraction. 
As the formation of insoluble rhbFGF suggested the 
existence of a protein-folding issue for this expression 
system, the effect of several chaperone combinations on 
hbFGF expression was investigated.  
 
 
The effect of trigger factor and/or GroEL – GroES on 
solubility ratio of rhbFGF 
 
In order to determine if trigger factor or GroELS alone 
could assist in the folding of hbFGF, we co-expressed 
pET-1008 along with pTf16 and pGro7 plasmids. Co-
expression studies were initiated by co-transforming pET-
1008 plus pTf16 or pGro7 into the same E. coli  host. The 
optimal culturing conditions for co-expressing of hbFGF 
with mentioned chaperone combinations are given in 
Table 1. 








Table 1. Optimal conditions for production of highest amount of soluble rhbFGF by expression systems.  
 





OrigamiB (DE3)  containing pET-1008 1 mM IPTG 37 5 
OrigamiB (DE3)  containing  pET-1008,pGro7 1 mM IPTG, 2 mg/ml L-arabinose 37 5 
OrigamiB (DE3)  containing  pET-1008,pG-KJE8 1 mM IPTG, 4 mg/ml L-arabinose, 2 ng/ml tetracycline 37 5 
OrigamiB (DE3)  containing  pET-1008,pTf16 1 mM IPTG, 4 mg/ml L-arabinose 37 5 
OrigamiB (DE3)  containing pET-1008, pKJE7 1 mM IPTG, 4 mg/ml L-arabinose 30 7 




measured, and it showed that co-expressing rhbFGF with 
GroEL-GroES decreased solubility ratio, while the other 
system which co-expresses TF along with hbFGF, 
significantly increased solubility ratio of target protein 
(Figure 2B). Furthermore, analysis of the extract was 
made from insoluble material which indicated that the vast 
majority of the rhbFGF was in insoluble fraction when 
hbFGF is co-expressed with GroELS; thus this system 
enhances accumulation of hbFGF. In contrast, trigger 
factor co-over-production could decrease hbFGF accu-
mulation (Figure 2A, Figure 2B). 
The plasmid that could express TF together with 
GroEL-GroES (pG-Tf2) was employed to examine the 
effects of TF plus GroEL-GroES combination on the 
production of soluble hbFGF. Under the optimal condition 
(Table 1) remarkable decrease in hbFGF amount in both 
soluble and insoluble fractions occurred using this combi-
nation (Figure 2C). 
 
 
The effect of DnaK/DnaJ/GrpE alone and together 
with GroEL – GroES on solubility ratio of rhbFGF  
 
Similar experiments carried out with pKJE7 and pG-KJE8 
plasmids, respectively included DnaK-DnaJ-GrpE and 
DnaK-DnaJ-GrpE-GroELS chaperones (Table 1). As 
shown in figure 3A, when the DnaK-DnaJ-GrpE chape-
rones were co-expressed with hbFGF, it was recovered 
from insoluble to soluble fraction and the amount of 
hbFGF in soluble fraction was increased. Furthermore, 
the remarkable decrease of hbFGF in insoluble fraction 
was observed. Co-expression of both DnaK-DnaJ-GrpE 
and GroEL-GroES chaperones (pG-KJE8 plasmid) along 
with rhbFGF increased the amounts of hbFGF in both 
soluble and insoluble fractions (Figure 3B).  
 
 
ELISA / western blot tests for rhbFGF 
 
Western blotting analysis demonstrated that produced 
recombinant hbFGF in soluble and insoluble fractions of 
6 expression systems could bind with the rabbit anti-
human basic fibroblast growth factor (bFGF) polyclonal 
antibody (Figure 4). The differences in quantity of pro-
duced soluble hbFGF by expression systems are clearly 
shown in Figure 4. The ELISA test revealed that all the 
chaperone combinations were not able to prevent the 
accumulation of hbFGF in insoluble fractions, but DnaK-
DnaJ-GrpE, GroEL-GroES plus DnaK-DnaJ-GrpE and 
especially TF chaperone systems were able to increase 
the solubility ratio of rhbFGF. On the other hand, co-
expression of GroEL-GroES and DnaK-DnaJ-GrpE plus 
GroEL-GroES along with rhbFGF also could increase 
accumulation of hbFGF in insoluble fraction (Table 2).  
 
 
Purification and Structural characterization of soluble 
rhbFGF 
 
The soluble fraction of two expression systems com-
prising OrigamiB (DE3) containing pET-1008 and 
OrigamiB (DE3) containing pET-1008, pTF16 were 
purified. Pre-purification was made using 30000 Da 
molecular weight cut off ultrafilter. The proteins that passed 
through the ultra-filter containing recombinant protein 
were run on carboxymethyl (CM) sepharose column. Re-
combinant hbFGF was bound to the column and eluted 
with 0.4 M NaCl. The purity of rhbFGF was more than 
95% in SDS-PAGE lane (Figure 5). Summary of purifica-
tion steps of rhbFGF is given in Table 3.  
Circular dichroism spectroscopy was applied to charac-
terize the secondary and tertiary structures of rhFGF, 
using denatured hbFGF as control. The CD profiles of the 
hbFGF and hbFGF that co-expressed with TF overlap 
and showed significant presence of beta sheet (Figure 6). 
Fluorescence spectroscopy was employed to investigate 
the quality of rhbFGF folding. Both produced hbFGF 
exhibited very low fluorescence emission while denatured 





Efficient folding of newly synthesized proteins relies on 
support from molecular chaperones, which is employed 
to prevent protein misfolding and aggregation in  the  cell. 
Chaperones that bind nascent chain polypeptide, 
including trigger factor and heat shock protein (Hsp) 70, 
stabilize the extension of polypeptide chains on ribo- 
somes. Folding in the cytoplasm is attained  by  releasing 








Figure 2. SDS-PAGE analysis. The soluble (S) and insoluble (In) cell proteins. (A) Induced E. coli OrigamiB 
(DE3) co-transformed with pET-1008 and pGro7; (B) induced E. coli OrigamiB (DE3) co-transformed with pET-




polypeptides from these factors or after transport of newly 
synthesized proteins to chaperonins (Gething and 
Sambrook, 1992; Hartl, 1996; Frydman, 2001). Although 
the substrate specificity of these chaperone systems has 
been characterized and an enormous progress in under-
standing chaperone-mediated protein folding processes 
has been achieved, the success of chaperone co-
production in increasing soluble protein is not predictable 
from properties of recombinant protein (Baneyx and 
Mujacis, 2004; Hoffmann and Rinas, 2004; Ventura and 
Villaverde, 2006). 
Trigger factor is a 48 kDa protein which binds to ribo-
some and interacts with nascent chains polypeptides 
(Goldberg, 2003). We found that over expression of 
trigger factor can remarkably increase production of 
soluble hbFGF, hence decrease the amount of insoluble 
hbFGF. In contrast, co-expression of TF along with 
GroEL-GroES significantly decreases both soluble and 
insoluble hbFGF, such observation is in agreement with 
previous findings that TF binds to GroEL and increases 
its affinity for certain proteins in order to promote their 
folding or degradation (Kondor et al., 1995). 
According to our experiments, it seems that the effect 
of over expression of TF is similar to the effect of DnaK-
DnaJ-GrpE chaperone team in solubilization of rhbFGF 
and reduction of protein aggregation. Our data also 
coincident with another studies suggesting TF and DnaK 
DnaJ-GrpE have similar roles during protein folding 
process and TF has an overlapping chaperone function 
with the Hsp70, DnaK and DnaJ,  in  holding  polypeptide 






Figure 3. SDS-PAGE analysis. The soluble (S) and insoluble (In) cell proteins. (A) Induced E. 
coli OrigamiB (DE3) co-transformed with pET-1008 and pKJE7; (B) induced E. coli OrigamiB 






Figure 4.  Western blot analysis of soluble and insoluble fractions of six expression systems.  




Table 2. The amount of hbFGF in the soluble and insoluble cell fractions of induced E. coli OrigamiB (DE3) strain co-
transformed with pET-1008 and chaperone plasmids was quantified by ELISA kit.  
 
Cell protein of expression system 
Soluble hbFGF 
(mg/ l culture) 
Insoluble hbFGF 
(mg/l culture) 
Induced OrigamiB (DE3)  containing pET-1008 34 256 
Induced OrigamiB (DE3)  containing  pET-1008,pGro7 15.3 284.95 
Induced OrigamiB (DE3)  containing  pET-1008,pG-KJE8 54 263.2 
Induced OrigamiB (DE3)  containing  pET-1008,pTf16 187 2.3 
Induced OrigamiB (DE3)  containing pET-1008, pKJE7 84 6.1 
Induced OrigamiB (DE3)  containing  pET-1008,pGtf2 0 0 
Uninduced OrigamiB (DE3) containing pET-1008 0 0 






Figure 5. Lane 1, 3: Purification of supernatant of 1 L cell (induced OrigamiB (DE3) containing pET-1008) lysate; 




chains in a state competent for folding (Deuerling et al., 
1999; Teter et al., 1999).  
Solublization of rhbFGF by co-expression of chaperone 
teams from pG-KJE8 and pGro7 prove that high levels of 
GroEL-GroES individually and together with DnaJ/DnaK/ 
GrpE can enhance accumulation of hbFGF in inclusion 
bodies. Co-production of chaperones comprises DnaK 
and GroEL family with recombinant proteins been 
traditionally examined in order to increase the amount of 
soluble protein (Goloubinoff et al., 1989; Blum et al., 
1992; Baneyx and Palumbo, 1999). Moreover, in some 
cases during over expression of DnaK, even accumu-
lation of inclusion bodies can occur (Petersson et al., 
2004). 
DnaK and GroEL family also associate with inclusion 
bodies. DnaK is localized preferably on the surface of 
inclusion bodies. GroEL is distributed in the cytoplasm, 
found inside of inclusion bodies (Carri’o and Villaverde, 
2005). The precise function of the DnaK and GroEL in 
inclusion body metabolism is not yet understood. Empi-
rical results are even consistent with an effective role of 
GroEL in the deposition of misfolded protein into inclusion 
bodies (Carri’o and Villaverde, 2003). 
In the current study, co-production of GroELS alone or 
GroELS in addition to DnaK-DnaJ-GrpE enhanced accu-
mulation of hbFGF in inclusion bodies but co-expression 
of DnaK-DnaJ-GrpE along with hbFGF could decrease 
aggregation.  




Table 3. (A) Summary of purification steps of 1 L induced OrigamiB (DE3) containing 
pET-1008 culture; (B) summary of purification of 1 L induced OrigamiB (DE3) 
containing pET-1008, pTF16 culture. 
 
Purification step Volume Total protein (mg/ml) Recovery (%) 
A 
Supernatant    1 L 174 100 
30000 Da Ultrafilter            540 ml 57.8 72.3 
CM Sepharose                   10 ml 3.46 66.2 
B 
Supernatant   1 L 183 100 
30000 Da Ultrafilter            540 ml 94 75.3 










Our results strongly suggest the important role of 
GroEL in stabilization of rhbFGF in inclusion bodies, 
while the DnaK-DnaJ-GrpE or TF operating systems 
reveal a direct role in disaggregating target protein. This 
clearly shows that GroELS chaperonins are not essential 
for the formation of soluble hbFGF, but DnaK family and 
more importantly trigger factor are involved in promoting 
rhbFGF folding and, in promoting degradation of the 
abnormal and unstable protein in case folding and 
refolding is not possible. Using trigger factor we obtained 
approximately 4 times more soluble protein than in cells 
producing only hbFGF. In our previous work, we found 
that rhbFGF produced by induced OrigamiB (DE3) con-
taining pET-1008 culture is biologically active and has 
good quality comparable with commercial one (Alibolandi 
et al., 2010).  
Identical patterns in CD spectra between rhbfgf 
expressed alone and rhbfgf co-expressed with TF 
suggests their secondary and tertiary structure is similar. 
Quantitative analysis of the CD spectra also indicate  that  






Figure 7. Relative fluorescence intensity of recombinant hbFGF produced in Escherichia coli cells 




rhbFGF (produced by both expression systems) are 
predominantly in beta-sheet and other conformations with 
very little alpha-helix fraction. These results are in agree-
ment with earlier observations (Prestrelski et al., 1991).  
It is well established that fluorescence intensity obtain-
ed at an excitation wavelength of 295 nm correlates with 
the exposure of hydrophobic tryptophan residues on the 
surface of the polypeptide (Ladokhin et al. 2000) and 
hence the extent of protein unfolding. hbFGF carry 8 
tryptophan residues (Dubey et al. 2005). Fluorescence 
emission of purified recombinant hbFGF exhibited an 
emission characteristic that was comparable to native 
hbFGF. Here, we showed purified recombinant hbFGFs 
had very low emission in comparison with denatured 
hbFGF.  
Both CD spectra and fluorescence emission indicate 
that the significant increase in solubility ratio did not alter 
the secondary and tertiary structure of rhbFGF. This out-
come paves the way for broad use of molecular chape-
rone in the in vivo folding of recombinant therapeutic 
proteins, where structure conservation is pre-requisite for 





rhbFGF, Recombinant human basic fibroblast growth 
factor; LB, Lauria Bertani; PMSF, phenylmethylsulfonyl 
fluoride; ELISA, enzyme-linked immunosorbent assay; 
CD, circular dichroism; SDS-PAGE, sodium dodecyl 
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